Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma
2019
Purpose of Review
The clinical role of fluorine-18 fluoro-2-deoxyglucose (FDG)-positron emission tomography (PET) in renal cell carcinoma (RCC) is still evolving. Use of FDG PET in RCC is currently not a standard investigation in the diagnosis and staging of RCC due to its renal excretion. This review focuses on the clinical role and current status of FDG PET and PET/CT in RCC.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
89
References
9
Citations
NaN
KQI